Mohan Tarun Shyam, Datta Pallab, Nesaei Sepehr, Ozbolat Veli, Ozbolat Ibrahim T
Centre for Healthcare Science and Technology, Indian Institute of Engineering Science and Technology, Shibpur, Howrah, West Bengal, India.
Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research (NIPER), Kolkata, West Bengal, India.
Prog Biomed Eng (Bristol). 2022 Apr;4(2). doi: 10.1088/2516-1091/ac631c. Epub 2022 Apr 20.
In the last decade, bioprinting has emerged as a facile technique for fabricating tissues constructs mimicking the architectural complexity and compositional heterogeneity of native tissues. Amongst different bioprinting modalities, extrusion-based bioprinting (EBB) is the most widely used technique. Coaxial bioprinting, a type of EBB, enables fabrication of concentric cell-material layers and enlarges the scope of EBB to mimic several key aspects of native tissues. Over the period of development of bioprinting, tissue constructs integrated with vascular networks, have been one of the major achievements made possible largely by coaxial bioprinting. In this review, current advancements in biofabrication of constructs with coaxial bioprinting are discussed with a focus on different bioinks that are particularly suitable for this modality. This review also expounds the properties of different bioinks suitable for coaxial bioprinting and then analyses the key achievements made by the application of coaxial bioprinting in tissue engineering, drug delivery and in-vitro disease modelling. The major limitations and future perspectives on the critical factors that will determine the ultimate clinical translation of the versatile technique are also presented to the reader.
在过去十年中,生物打印已成为一种简便的技术,用于制造模仿天然组织的结构复杂性和成分异质性的组织构建体。在不同的生物打印方式中,基于挤出的生物打印(EBB)是使用最广泛的技术。同轴生物打印作为EBB的一种类型,能够制造同心的细胞-材料层,并将EBB的范围扩大到模仿天然组织的几个关键方面。在生物打印的发展过程中,集成有血管网络的组织构建体一直是同轴生物打印在很大程度上实现的主要成就之一。在这篇综述中,将讨论同轴生物打印在构建体生物制造方面的当前进展,重点关注特别适用于这种方式的不同生物墨水。这篇综述还阐述了适用于同轴生物打印的不同生物墨水的特性,然后分析了同轴生物打印在组织工程、药物递送和体外疾病建模中的应用所取得的关键成就。还向读者介绍了决定这项通用技术最终临床转化的关键因素的主要局限性和未来前景。